Oncology pharmaceutical market in India, a leading segment of the overall pharmaceuticals market and is the fourth largest in volume and eighth largest in …
Oncology pharmaceutical market is expected to show steady growth owing to the increasing cancer cases, especially lung and breast cancer. Cancer is the second largest cause of death in the country. According to the National Cancer Registry Program (NCRP) there are 2.5 mn cancer patients at any point of time with approximately 450,000 cancer related deaths are being registered every year.
The report begins with the market overview section which provides an insight into the global market, highlighting the market size and growth. It also provides the information of top 5 cancer drugs based on the sales figures. It then moves onto the Indian market, with a focus on market size and growth. This section highlights the major regions in the country with high prevalence of cancer cases. It also provides import and export figures of cancer drugs in India in terms of value. Regional break-up of the imports and exports have been included.
A number of driving factors are acting as catalysts for the high growth of the industry. A detailed analysis of the drivers has been included in the next section. Increasing cancer cases, changes in the treatment scenario, development of alternative cancer therapies, increasing FDI and increase in the number of cancer health insurances are considered to be the major growth factors. The key challenges include increased competition, drug patent problems and drug portfolio management problems. Large numbers of domestic and foreign pharmaceutical companies are currently operating in the market and it transforms the market into a highly competitive one. Drug portfolio management is a time consuming event and it also increases the operating cost of the company.
The number of cancer patients is increasing in the country in an exponential rate. The Government is taking various steps to promote the anti-cancer pharmaceutical market. The government initiatives section highlights the PPP R&D projects started in the country. It also analyses the various initiatives undertaken to reduce prices of cancer drugs, the various cancer control programmes implemented and the changes in the custom duty structure. These initiatives will help to reduce the prices of the cancer drugs in the country and in turn will increase the affordability among the cancer patients.
A brief overview of the drug regulations and patents is presented in the next section. It focuses the different stages of clinical trial that a drug must pass through. Detailed information on the drug regulations in India controlled by Central and State Governments and drugs approved for marketing has been provided. The section also provides a list of important patent approvals by US Food and Drug Administration (FDA).
The competition section provides an overview of the competitive landscape in the industry. It includes a brief profile of the major players in the market along with their financials. This section also includes the latest developments in the industry and it covers information such as patent approval, introduction of new drug molecules for oncology treatment.
Research On India (ROI) is Netscribes’ leading source for market intelligence on emerging sectors in India. Our topics provide a holistic view of an industry and are a spring board for entry strategies, private equity and venture capital investments, investor presentations and management discussions.
For more details on the content of the report and our services you can contact us at